DR. GEORGE F. SMITH, MD
Marriage and Family Therapists at Columbia St, Mason, MI

License number
Michigan 4301039078
Category
Osteopathic Medicine
Type
Family Medicine
Address
Address 2
800 E Columbia St, Mason, MI 48854
PO Box 13008, Lansing, MI 48901
Phone
(517) 244-8940
(517) 244-8941 (Fax)
(517) 364-6253
(517) 364-6208 (Fax)

Organization information

See more information about GEORGE F. SMITH at bizstanding.com

George F Smith

1507 S Genesee Dr, Lansing, MI 48915

Status:
Inactive
Industry:
Business Services at Non-Commercial Site, Nonclassifiable Establishments

Professional information

George F Smith Photo 1

Dr. George F Smith, Mason MI - MD (Doctor of Medicine)

Specialties:
Family Medicine
Address:
Mason Family Health Center
800 E Columbia St, Mason 48854
(517) 244-8940 (Phone)
Certifications:
Family Practice, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mason Family Health Center
800 E Columbia St, Mason 48854
Sparrow Hospital
1215 East Michigan Ave, Lansing 48909
Education:
Medical School
Michigan State University
Graduated: 1976
Sparrow Hospital Sparrow Health System
University Of Michigan-Flint


George Smith Photo 2

Professor At Michigan State University

Position:
Professor at Michigan State University
Location:
Lansing, Michigan Area
Industry:
Research
Work:
Michigan State University - Professor


George Frederick Smith Photo 3

George Frederick Smith, Mason MI

Specialties:
Family Medicine
Work:
Sparrow Family Health Ctr
800 E Columbia St, Mason, MI 48854
Education:
Michigan State University(1976)


George Smith Photo 4

Consumer Goods Professional

Location:
Lansing, Michigan Area
Industry:
Consumer Goods


George Smith Photo 5

Corticotropin Releasing Factor Receptor 2 Deficient Mice And Uses Thereof

US Patent:
6353152, Mar 5, 2002
Filed:
Jul 14, 2000
Appl. No.:
09/616937
Inventors:
Kuo-Fen Lee - Del Mar CA
Wylie W. Vale - La Jolla CA
Tracy L. Bale - San Diego CA
George W. Smith - Mason MI
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A01K 67027
US Classification:
800 18, 800 3, 800 9
Abstract:
The present invention provides transgenic mice deficient in corticotropin releasing factor receptor 2. Corticotropin releasing factor is a critical integrator of the hypothalamic-pituitary-adrenal axis in response to stress. CRF and its related molecule urocortin bind CRF receptor 1 and CRFR2 with distinct affinities. CRFR2 mutant mice were hypersensitive to stress and displayed increased anxiety-like behavior. Mutant mice had normal basal feeding and weight gain, but exhibited decreased food intake following food deprivation. Intravenous UCN dramatically decreased the mean arterial pressure in the controls but had no effect in the mutants. A deficiency of CRFR2 results in a significant increase in urocortin mRNA in the rostral region of the Edinger Westphal and a significant increase in CRF mRNA in central nucleus of the amygdala. These results demonstrate that the CRFR2 mutant mice, opposed to CRFR1 mutant mice, have an increased sensitivity to stress and display anxiety-like behavior. These mice are useful for the study of anxiety, depression, and the physiology of the HPA axis.


George Smith Photo 6

Method Of Inhibiting Angiogenesis By Administration Of A Corticotropin Releasing Factor Receptor 2 Agonist

US Patent:
7674463, Mar 9, 2010
Filed:
Nov 16, 2000
Appl. No.:
09/714692
Inventors:
Kuo-Fen Lee - Del Mar CA, US
Wylie W. Vale - La Jolla CA, US
Tracy L. Bale - San Diego CA, US
George W. Smith - Mason MI, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61K 38/16, C07K 14/435
US Classification:
4241841, 4241981, 514 2, 514 12, 530350
Abstract:
The present invention provides transgenic mice deficient in corticotropin releasing factor receptor 2 (CRFR2). Mice deficient for CRFR1 exhibit decreased anxiety-like behavior and a decreased stress response. In contrast, CRFR2 null mutant mice are hypersensitive to stress and display increased anxiety-like behavior. These mice are useful for the study of anxiety, depression, and the physiology of the HPA axis. CRFR2 null mutant mice also exhibit increased angiogenesis in all tissues examined. Thus, CRFR2 antagonists may be used to stimulate angiogenesis for the treatment of various conditions. In contrast, CRFR2 agonists may be used to inhibit angiogenesis. A combination of urocortin and bFGF was observed to stimulate rapid hair growth.


George Smith Photo 7

Self-Contained Clamp-Mounted Pivotal Arm Mailbox Signal Device Assembly

US Patent:
4190193, Feb 26, 1980
Filed:
Sep 27, 1978
Appl. No.:
5/946135
Inventors:
George T. Smith - Lansing MI
International Classification:
A47G 2912
US Classification:
232 35
Abstract:
A self-contained mailbox signal device assembly is provided which is selectively clamp-mountable against the exterior surface of a mailbox and which is provided with a gravity actuated pivotal signal arm. The pivotal signal arm is weighted at one end and is provided with a flag indicator signal portion at the other end thereof. The pivotal signal arm is adapted to be maintained in a substantially horizontal position when the weighted end thereof is supportably engaged by a support arm extension provided in the closed door of the mailbox. When the door of the mailbox is opened, the weighted portion of the signal arm disengages from the support arm extension and moves in a downward arc in response to gravitational pull. This causes the signal arm to pivotally move into its upright signal position with the weighted portion down and the indicator signal portion up so as to indicate to a remote observer that the mailbox has been opened and presumably mail has been deposited therein.